|
Investigating the cell of origin for bladder cancer
|
5R01CA193442-04
|
$474,774
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
5U10CA180884-05
|
$192,024
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Investigating mechanistic underpinnings and therapeutic potential of selective histone deacetylase and bromodomain inhibition for the treatment of non-small cell lung cancer
|
1K22CA222669-01
|
$182,485
|
ADEEGBE, OLAKUNLE
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Identifying the Drivers and Targeting Chemo Resistance in Ovarian Cancer
|
5R01CA211648-02
|
$432,788
|
ADLI, MAZHAR
|
UNIVERSITY OF VIRGINIA
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
5U10CA180791-05
|
$922,200
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Role of Nix in pancreatic ductal adenocarcinoma
|
5F30CA200240-03
|
$49,524
|
ALAGESAN, BRINDA
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Treatment of glioma with nanocombretastatin with MRI monitoring
|
5R01CA206190-03
|
$344,269
|
ALI, MESER
|
Henry Ford Health System
|
|
Functional and Mechanistic Study of Histone Crotonylation in Hematological Malignancies
|
5R01CA204639-03
|
$698,696
|
ALLIS, CHARLES
|
ROCKEFELLER UNIVERSITY
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-49
|
$2,645,581
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Role of Tim-3 in determining T cell immunity
|
5R01CA187975-04
|
$377,666
|
ANDERSON, ANA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Swedish childhood cancers study
|
Z01 CP010183-00550
|
$2,170
|
Anderson, William
|
DCEG (NCI)
|
|
A clones genomic stability as biomarker of its DNA-damage resilience
|
5K99CA215256-02
|
$166,644
|
ANDOR, NOEMI
|
STANFORD UNIVERSITY
|
|
Clinical bacterial isolate engineered as an immunotherapy for prostate cancer
|
5F30CA203472-03
|
$49,524
|
ANKER, JONATHAN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-05
|
$605,293
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Age and Diet: Major interacting factors that drive sporadic intestinal cancer
|
5R01CA174432-06
|
$660,173
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Collaborative Human Tissue Network (CHTN)
|
5UM1CA183713-05
|
$841,585
|
AYERS, LEONA
|
OHIO STATE UNIVERSITY
|
|
O-GlcNAcylation of Ewing sarcoma proteins in chromosomal maintenance
|
1R03CA223949-01
|
$89,000
|
AZUMA, MIZUKI
|
UNIVERSITY OF KANSAS LAWRENCE
|
|
Interferon Activated Necroptosis as a New Therapeutic Avenue for Kidney Cancer
|
5R01CA168621-05
|
$379,725
|
BALACHANDRAN, SIDDHARTH
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Multi-Site Development & Evaluation of a Quantitative 3D Hyperpolarized C-13 MRI Clinical Prostate Cancer Exam
|
5R01CA211150-02
|
$643,101
|
BANKSON, JAMES
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Uncovering the role of individual RNA helicases in cancer through specific chemical inhibition
|
5F30CA203522-03
|
$49,524
|
BARKOVICH, KRISTER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-05
|
$1,394,352
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
The roles of TRIM24 in breast cancer
|
5R01CA214871-02
|
$402,021
|
BARTON, MICHELLE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Pain: Nerve/Tumor Interactions
|
5R01CA084233-07
|
$335,452
|
BEITZ, ALVIN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
The role of AXL-ABL axis in Barretts carcinogenesis
|
5R01CA193219-04
|
$361,425
|
BELKHIRI, ABBES
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Biochemical Analyses of Type II DNA Topoisomerases
|
5R01CA077373-21
|
$445,382
|
BERGER, JAMES
|
JOHNS HOPKINS UNIVERSITY
|
|
Epigenetic regulation by tumor suppressor p53
|
5R01CA078831-19
|
$352,848
|
BERGER, SHELLEY
|
UNIVERSITY OF PENNSYLVANIA
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-06
|
$503,410
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
|
Z01 SC 004020
|
$1,350,223
|
Berzofsky, Jay
|
CCR (NCI)
|
|
3D Prostate Histochemometry to Predict Disease Recurrence
|
5R01CA197516-03
|
$400,610
|
BHARGAVA, ROHIT
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
Genome maintenance by Hdacs1,2 and their inhibition for Pre-B leukemia therapy
|
5R01CA188520-04
|
$340,838
|
BHASKARA, SRIVIDYA
|
UNIVERSITY OF UTAH
|
|
Delineating the mechanisms and clinical utility of mtDNA mutagenesis in cancer
|
5R01CA204894-02
|
$402,600
|
BIELAS, JASON
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Characterization of YAP as a rational companion target in lung cancer
|
5R01CA204302-02
|
$362,569
|
BIVONA, TREVER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
ITSC for Leukemia: Novel Molecular Strategies for NCTN: Individualized Therapie
|
5U10CA180861-05
|
$684,551
|
BLOOMFIELD, CLARA
|
OHIO STATE UNIVERSITY
|
|
Antitumor Antibiotics
|
5R01CA042056-35
|
$462,801
|
BOGER, DALE
|
SCRIPPS RESEARCH INSTITUTE
|
|
Chemical probes for specific targeting of matrix metallo proteases
|
5R01CA179253-05
|
$333,038
|
BOGYO, MATTHEW
|
STANFORD UNIVERSITY
|
|
Targeting GLI-dependent Transcription by GANT61 in Colon Cancer
|
5R01CA183921-04
|
$548,628
|
BOOHAKER, REBECCA
|
SOUTHERN RESEARCH INSTITUTE
|
|
Dissection of eIF4E dependent mRNA export
|
5R01CA080728-18
|
$210,799
|
BORDEN, KATHERINE
|
UNIVERSITY OF MONTREAL
|
|
Ultrasound Molecular Imaging to Assess Therapeutic Response
|
5R01CA195051-04
|
$572,327
|
BORDEN, MARK
|
UNIVERSITY OF COLORADO
|
|
Targeted proteomics to aid in the management of patients with stage IA lung adeno
|
1R21CA223335-01
|
$170,738
|
BORGIA, JEFFREY
|
RUSH UNIVERSITY MEDICAL CENTER
|
|
Summer Research Experience in Cancer (SuRE-C)
|
5R25CA206972-02
|
$234,533
|
BOUTON, AMY
|
UNIVERSITY OF VIRGINIA
|
|
Johns Hopkins University NCTN Lead Academic Site Program
|
5U10CA180802-05
|
$575,595
|
BRAHMER, JULIE
|
JOHNS HOPKINS UNIVERSITY
|
|
Using Second Harmonic Generation to Predict Metastatic Outcome in Colon Adenocarcinoma
|
5R21CA208921-02
|
$167,475
|
BROWN, EDWARD
|
UNIVERSITY OF ROCHESTER
|
|
NCI NCTN-Network Lead Academic Site at UPCI
|
5U10CA180844-05
|
$898,424
|
BRUFSKY, ADAM
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Analysis of Intratumoral Crosstalk in Clonal Populations of OvarianTumor Cells
|
5R01CA181543-05
|
$394,740
|
BRUGGE, JOAN
|
HARVARD MEDICAL SCHOOL
|
|
Molecular Probes Shed Light on Magnesium Homeostasis
|
5R01CA217817-02
|
$347,821
|
BUCCELLA, DANIELA
|
NEW YORK UNIVERSITY
|
|
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
|
5U10CA180867-05
|
$1,302,199
|
BURSTEIN, HAROLD
|
DANA-FARBER CANCER INST
|
|
Electronic cleansing based on effective atomic numbers in dual-energy CT colonography
|
1R03CA223711-01
|
$84,250
|
CAI, WENLI
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Complex Role of HSF1 in Breast Cancer
|
5R01CA176326-05
|
$355,719
|
CALDERWOOD, STUART
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
The Ohio State University Comprehensive Cancer Center
|
3P30CA016058-33S1
|
$89,606
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Malignant melanoma studies using iPS derived melanocytes and Zebrafish
|
5F31CA196305-04
|
$28,524
|
CALLAHAN, SCOTT
|
SLOAN-KETTERING INST CAN RESEARCH
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|